Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Liposomal Cytarabine for Leptomeningeal Metastasis in Breast Cancer
NCT01645839Phase 3Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Aug 2011
- Primary completion
- Aug 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal cytarabine in leptomeningeal metastases (LM), sponsored by Centre Oscar Lambret. Started Aug 2011; status: completed.
02
Drugs
liposomal cytarabine
03
Conditions
leptomeningeal metastases (LM)
Beyond the preview
Go deeper on NCT01645839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01645839.